Drug interactions
Axicabtagene ciloleucel + Mitoxantrone
Severity: Major
Axicabtagene ciloleucel and Mitoxantrone: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Mitoxantrone is a myelosuppressive, immunosuppressive cytotoxic agent. Recent or concurrent use around CAR T therapy may impair T-cell collection and expansion and increase infection and cytopenia risk.
What this interaction means in plain words
Axicabtagene ciloleucel and Mitoxantrone can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Axicabtagene ciloleucel belongs to Oncology; Mitoxantrone belongs to Central Nervous System.
Why it happens
Additive cytotoxic and immunosuppressive effects on lymphocytes and marrow.
What to do
Observe an adequate washout of mitoxantrone before leukapheresis, and avoid it after infusion unless clinically required. Monitor blood counts and infection closely.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Axicabtagene ciloleucel and Mitoxantrone, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Mitoxantrone
Other interactions of Axicabtagene ciloleucel
Frequently asked questions
Can I take Axicabtagene ciloleucel with Mitoxantrone?
MediHelp rates the interaction as major. Axicabtagene ciloleucel and Mitoxantrone can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Mitoxantrone is a myelosuppressive, immunosuppressive cytotoxic agent. Recent or concurrent use around CAR T therapy may impair T-cell collection and expansion and increase infection and cytopenia risk.
How serious is the interaction between Axicabtagene ciloleucel and Mitoxantrone?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Observe an adequate washout of mitoxantrone before leukapheresis, and avoid it after infusion unless clinically required. Monitor blood counts and infection closely.
What other medicines interact with Mitoxantrone?
MediHelp also lists interactions of Mitoxantrone with, for example, Adenovirus types 4 and 7 live, Belatacept, Brexucabtagene autoleucel. The full list is on the Mitoxantrone page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
